Abstract
Epidermal growth factor (EGF) receptor-overexpression is characteristic of many human tumours of epithelial origin and has been correlated with unfavourable patient prognosis. Its involvement in the malignant process, its elevated expression in tumours and its accessibility on the tumour cell surface make the EGF receptor a potential target for directed tumour therapy. We have previously characterized a recombinant antibody - Pseudomonas exotoxin A fusion protein, scFv(225)-ETA, which displayes antitumoral activity towards EGF receptor-overexpressing tumour cells but is less potent in tumour cell killing than TGF-alpha-ETA, a recombinant toxin using the natural EGF receptor ligand transforming growth factor alpha (TGF-alpha) as a targeting domain. Here, we describe the construction and functional characterization in vitro of a novel single-chain antibody-toxin, scFv(14E1)-ETA, based on the independently isolated EGF receptor-specific monoclonal antibody 14E1. ScFv(14E1)-ETA binds to an EGF receptor epitope that is very similar or identical to that of scFv(225)-ETA with nine times higher affinity than the latter and displays more than tenfold higher cytotoxic activity on EGF receptor-overexpressing tumour cells. ScFv(14E1)-ETA c...Continue Reading
Citations
Mar 24, 2005·Cancer Metastasis Reviews·Helmout Modjtahedi
Oct 16, 2015·Cancer Biology & Therapy·Jie MengLiang Shan
Oct 6, 2020·Oncotarget·Fleury Augustin Nsole BitegheStefan Barth
Oct 23, 1997·International Journal of Cancer. Journal International Du Cancer·U AltenschmidtW Wels
Apr 23, 2015·Journal of Cancer Research and Clinical Oncology·Judith NiesenStefan Barth
Aug 1, 1998·Japanese Journal of Cancer Research : Gann·Y KanetaS Nozawa
Mar 20, 1998·International Journal of Cancer. Journal International Du Cancer·M SchmidtW Wels
Sep 2, 2008·Cancer Gene Therapy·D T HoT W Hermiston
Apr 20, 1999·Oncogene·M SchmidtW Wels
Feb 14, 1998·International Journal of Cancer. Journal International Du Cancer·E GenerschR B Lichtner
Jul 6, 2007·Journal of Neuro-oncology·Jos M A KuijlenWilfred F A den Dunnen
Mar 30, 2000·International Journal of Cancer. Journal International Du Cancer·M AzemarW Wels
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Mathias Schmidt, Winfried Wels
Sep 23, 2009·Expert Opinion on Therapeutic Targets·Lieven HuangRudi Beyaert
Sep 24, 2005·Cell Death and Differentiation·B DälkenW S Wels
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·K Krensel, R B Lichtner
Jan 7, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shuxian SongYuhong Xu
Jul 29, 2017·BioMed Research International·Shaowei ZhuLiang Shan
May 7, 2016·Toxins·Nathan Simon, David FitzGerald
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin MichaelisJindrich Cinatl
Jan 16, 2008·Biomacromolecules·Thommey P ThomasJames R Baker
Oct 7, 2005·Critical Reviews in Oncology/hematology·Nicholas W Choong, Ezra E W Cohen
Jul 5, 2012·Bioconjugate Chemistry·Robert A JabulowskyWinfried S Wels
Jan 19, 2008·Immunology Letters·Elza FriedländerGyörgy Vereb